Cargando...
Checkpoint inhibitors in gastrointestinal cancers: Expectations and reality
Immune checkpoint inhibitors represent revolutionary anti-cancer agents, being rapidly approved in different malignancies and settings. Gastrointestinal (GI) cancers represent a wide variety of tumors with specific characteristics and different responses to various therapeutic alternatives; while so...
Guardado en:
| Publicado en: | World J Gastroenterol |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Baishideng Publishing Group Inc
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5423038/ https://ncbi.nlm.nih.gov/pubmed/28533658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v23.i17.3017 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|